As of 2025-07-12, the Relative Valuation of NGM Biopharmaceuticals Inc (NGM) is (21.84) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.54 USD, the upside of NGM Biopharmaceuticals Inc based on Relative Valuation is -1517.9%.
The range of the Relative Valuation is (19.18) - (23.88) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.9x - 14.0x | 11.4x |
| Forward P/E multiples | 11.2x - 17.4x | 14.2x |
| Fair Price | (19.18) - (23.88) | (21.84) |
| Upside | -1345.1% - -1650.9% | -1517.9% |
| Date | P/E |